Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic ...

Satio announced today that it completed a Small Business Innovation Research (SBIR) contract for its intradermal drug ...

and active targeting of liposomal or other nanomedicine drug delivery systems (DDS). Molecular subtypes of HGSC will present a further challenge to the development and testing of targeted ...

and active targeting of liposomal or other nanomedicine drug delivery systems (DDS). Molecular subtypes of HGSC will present a further challenge to the development and testing of targeted ...